Skip to content

Nilogen Oncosystems vs PathAI

Nilogen Oncosystems logo

Nilogen Oncosystems

We analyze cancer drug responses using fresh patient tumor tissue with intact tumor microenvironment

17 employees · est. 2013 · Tampa, United States

VS
PathAI logo

PathAI

Improving patient outcomes with AI-powered pathology

277 employees · est. 2016 · Boston, United States

Nilogen Oncosystems is the older company (2013 vs 2016); PathAI is the larger of the two.

Side-by-Side Comparison

Nilogen Oncosystems PathAI
Founded
2013 older 2016
Headquarters
Tampa, United States Boston, United States
Employees
17 277 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Not tracked yet Debt Financing
Total Funding
Not tracked yet $355.20M
Funding Rounds
Not tracked yet 6
Services
Not tracked yet AI-Powered Pathology Solutions, Digital Pathology Platform AISight®, Translational Research Services, Clinical Development Services, Real-World Data Analysis, Companion Diagnostics Development, Biomarker Quantification
Target Customers
Not tracked yet Biopharma Companies, Academic Medical Centers, Reference Laboratories, Health Systems, Pathology Laboratories
Taxonomy
Cancer Drug DevelopmentImmuno-oncologyPrecision MedicineTumor Microenvironment AnalysisPreclinical Drug TestingCompanion Diagnostics +8 AI-Powered PathologyDigital PathologyOncologyImmuno-OncologyNeurodegenerative DiseaseCompanion Diagnostics +8
Website
nilogen.com pathai.com
Nilogen Oncosystems logo

About Nilogen Oncosystems

Nilogen Oncosystems is a biotechnology and healthcare company based in the United States that was founded in 2013. The company's primary focus is on revolutionizing cancer drug development and immuno-oncology. Their slogan, "We analyze cancer drug responses using fresh patient tumor tissue with inta...

PathAI logo

About PathAI

PathAI, founded in 2016, is carving a niche in the Biotechnology and Health Care sectors by focusing on AI-enhanced pathology. Their slogan, "Improving patient outcomes with AI-powered pathology," encapsulates their mission to leverage machine learning to enhance diagnostic accuracy and treatment ef...

Also comparing in this category

Comparing more than these two?

Get Nilogen Oncosystems, PathAI and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Nilogen Oncosystems compare?

A PDF of Nilogen Oncosystems and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Nilogen Oncosystems was founded in 2013, based in Tampa, United States, with 17 employees. Nilogen Oncosystems is a biotechnology and healthcare company based in the United States that was founded in 2013. The company's primary focus is on revolutionizing cancer drug development and immuno-. PathAI was founded in 2016, based in Boston, United States, with 277 employees. PathAI, founded in 2016, is carving a niche in the Biotechnology and Health Care sectors by focusing on AI-enhanced pathology. Their slogan, "Improving patient outcomes with AI-powered pathology," enc.
Nilogen Oncosystems has raised no disclosed funding and PathAI $355.20M. Latest stage: PathAI Debt Financing.
Both work in Biotechnology and Health Care and list immuno-oncology, precision medicine and companion diagnostics among their focus areas.

Compare Nilogen Oncosystems with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Nilogen Oncosystems on 12 Sep 2024, and PathAI on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout